Monte Rosa Therapeutics

GLUE · NASDAQ🇺🇸

Overview

Earnings Dividends Seasonality Metrics

Reported earnings 14 days ago

Total Revenue

$84.9M

Previous year: $1.06M

+7882.0%

EPS

$0.57

Previous year: -$0.53

-207.5%

Research and Development Expenses

$32.2M

Previous year: $27M

+19.1%

General and Administrative Expenses

$8.7M

Previous year: $8.99M

-3.1%

Total Operating Expenses

$40.9M

Previous year: $36M

+13.6%

Loading...

Monte Rosa Therapeutics

Monte Rosa Therapeutics

Unlock previous datapoints

Upgrade

Monte Rosa Therapeutics Revenue by Geographic Location

Revenue by Geographic Location

Switzerland Revenue

CapyFin.com

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Key Statistics

Market Cap

$1.32B

P/E Ratio

233.15

Sector

N/A

Industry

N/A

52-Week High

$25.3

52-Week Low

$3.69

Research and Development Expenses

$32.2M

General and Administrative Expenses

$8.7M

Total Operating Expenses

$40.9M

Interest Income, Net

$3.44M

Provision for Income Taxes

$822K

Products

Get in Touch

Resources

Monte Rosa Therapeutics

Monte Rosa Therapeutics

Monte Rosa Therapeutics

Monte Rosa Therapeutics Revenue by Geographic Location

Revenue by Geographic Location

Switzerland Revenue

Historical Earnings Impact

Avg. Return Before/After Earnings

Key Statistics